N-cyclopentyl-4-methyl-N-(2-piperazin-1-ylsulfonylethyl)benzamide;2,2,2-trifluoroacetic acid
C21H30F3N3O5S — CID 146061526
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopentyl-4-methyl-N-(2-piperazin-1-ylsulfonylethyl)benzamide;2,2,2-trifluoroacetic acid
N-cyclopentyl-4-methyl-N-(2-piperazin-1-ylsulfonylethyl)benzamide;2,2,2-trifluoroacetic acid (PubChem CID 146061526) has the molecular formula C21H30F3N3O5S and a molecular weight of 493.55 g/mol. Its IUPAC name is N-cyclopentyl-4-methyl-N-(2-piperazin-1-ylsulfonylethyl)benzamide;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | N-cyclopentyl-4-methyl-N-(2-piperazin-1-ylsulfonylethyl)benzamide;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 146061526 |
| Molecular Formula | C21H30F3N3O5S |
| Molecular Weight | 493.55 g/mol |
| Exact Mass | 493.19 |
| IUPAC Name | N-cyclopentyl-4-methyl-N-(2-piperazin-1-ylsulfonylethyl)benzamide;2,2,2-trifluoroacetic acid |
| SMILES | Cc1ccc(C(=O)N(CCS(=O)(=O)N2CCNCC2)C2CCCC2)cc1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C19H29N3O3S.C2HF3O2/c1-16-6-8-17(9-7-16)19(23)22(18-4-2-3-5-18)14-15-26(24,25)21-12-10-20-11-13-21;3-2(4,5)1(6)7/h6-9,18,20H,2-5,10-15H2,1H3;(H,6,7) |
| InChIKey | SLSYRPPMEBJBDR-UHFFFAOYSA-N |
| XLogP | 2.25 |
| TPSA | 107.02 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 493.55 |
| LogP ≤ 5 | 2.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146061526 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.